Clinical Trial

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

Study acronym: YOPD
Recruiting
View on ClinicalTrials.gov →
Summary
Young Onset Parkinson's disease (YOPD) refers to a group of patients in which the disease starts earlier in life (before the age of 50 years) and has a profound impact on most of patient's life. Current knowledge regarding the mechanisms leading to development of Parkinson's disease in younger individuals is lacking, but their understanding is crucial for the successful design of therapeutic strategies and stratifying patients for clinical trials. With this research the investigators aim to clarify the contribution of relevant biological processes in patients with Young onset Parkinson's disease to help understanding disease mechanisms and biomarkers.
Trial Details
NCT Number NCT07752355
Lead Sponsor NYU Langone Health
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Young Onset Parkinson Disease, Parkinson Disease
Enrollment 250 participants
Start Date 2024-02-28
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12